Clarification sought from Dishman Pharmaceuticals and Chemicals

28 Mar 2017 Evaluate

The Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals on March 28, 2017, with reference to the news flashed on CNBC TV18 dated March 28, 2017 quoting ‘US FDA Approves Zejula Capsules’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.